| scholarly article | Q13442814 |
| P2093 | author name string | Howard A Liebman | |
| Sandeep K Rajan | |||
| Byron M Espina | |||
| P2860 | cites work | The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 | Q29620136 |
| Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. | Q33331448 | ||
| HCV-associated thrombocytopenia: clinical characteristics and platelet response after recombinant alpha2b-interferon therapy | Q33333436 | ||
| Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis | Q33337510 | ||
| Treatment of hepatitis C related thrombocytopenia with interferon alpha | Q33340288 | ||
| Steroid-refractory chronic idiopathic thrombocytopenic purpura associated with hepatitis C virus infection | Q33341932 | ||
| Thrombocytopenia during interferon alfa therapy | Q33380496 | ||
| Hepatitis C virus infection and autoimmune thrombocytopenic purpura | Q33496566 | ||
| High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with lymphoproliferative and connective tissue disorders. | Q33497218 | ||
| Thrombocytopenia associated with hepatitis C viral infection | Q33497636 | ||
| Interferon increases serum thrombopoietin in patients with chronic hepatitis C. | Q33499352 | ||
| Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C. | Q33502832 | ||
| Autoimmune thrombocytopenia associated with hepatitis C virus infection | Q33502899 | ||
| Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C. | Q33504098 | ||
| Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies | Q34580419 | ||
| Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients | Q40289215 | ||
| Hepatitis C: A Multifaceted Disease: Review of Extrahepatic Manifestations | Q40483846 | ||
| Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies. | Q42978301 | ||
| The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines | Q43034754 | ||
| Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County | Q43712744 | ||
| Diffuse recidivant alveolar hemorrhage in a patient with hepatitis C virus-related mixed cryoglobulinemia | Q45749676 | ||
| Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma | Q45760281 | ||
| Autoimmune thrombocytopenia and hepatitis C virus infection | Q45765974 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| Immune thrombocytopenic purpura | Q3410984 | ||
| thrombocytopenia | Q585285 | ||
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 818-824 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura | |
| P478 | volume | 129 |
| Q33371795 | Adult autoimmune thrombocytopenia: diagnosis and treatment |
| Q33372361 | Autoimmune thrombocytopenia induced by PEG-IFN-alpha plus ribavirin in hepatitis C. |
| Q26775733 | Benign and Malignant Hematological Manifestations of Chronic Hepatitis C Virus Infection |
| Q33387808 | Considerations in the management of hepatitis C virus-related thrombocytopenia with eltrombopag |
| Q33380302 | Cytomegalovirus-associated idiopathic thrombocytopenic purpura in Chinese children |
| Q54211951 | Emerging Concepts in Immune Thrombocytopenia. |
| Q38254121 | Extrahepatic immune related manifestations in chronic hepatitis C virus infection |
| Q90602246 | Guideline on immune thrombocytopenia in adults: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Project guidelines: Associação Médica Brasileira - 2018 |
| Q38497354 | Hepatitis C virus and autoimmunity |
| Q35731058 | Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infection |
| Q90029492 | How do we diagnose immune thrombocytopenia in 2018? |
| Q26997803 | Human platelets and their capacity of binding viruses: meaning and challenges? |
| Q33414858 | Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines |
| Q26830918 | Immune thrombocytopenia |
| Q33395624 | Immune thrombocytopenia: no longer 'idiopathic'. |
| Q33402517 | Immunological HCV-associated thrombocytopenia: short review |
| Q33412382 | Immunological alterations in hepatitis C virus infection |
| Q33432245 | Impact of Helicobacter pylori eradication on refractory thrombocytopenia in patients with chronic HCV awaiting antiviral therapy |
| Q33401841 | Mechanism of thrombocytopenia in chronic hepatitis C as evaluated by the immature platelet fraction |
| Q27488341 | Molecular mimicry and immune thrombocytopenia |
| Q33421239 | Non-cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy |
| Q33394547 | Pathobiology and treatment of hepatitis virus-related thrombocytopenia |
| Q33383468 | Pathobiology of secondary immune thrombocytopenia |
| Q33420327 | Prevalence of thrombocytopenia among Chinese adult antiretroviral-naïve HIV-positive patients |
| Q26773278 | Rheumatic manifestations of hepatitis C virus chronic infection: Indications for a correct diagnosis |
| Q33386133 | Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy |
| Q27490427 | Risk of Immune Thrombocytopenic Purpura and Autoimmune Hemolytic Anemia Among 120 908 US Veterans With Hepatitis C Virus Infection |
| Q33384235 | The ITP syndrome: pathogenic and clinical diversity |
| Q33412844 | The effect of antiviral therapy on hepatitis C virus-related thrombocytopenia: a case report |
| Q33406725 | The role of Epstein-Barr virus (EBV) and cytomegalovirus (CMV) in immune thrombocytopenia |
| Q33414386 | The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia |
| Q30240119 | Thrombocytopenia and infections |
| Q48592088 | Thrombocytopenia in patients with chronic liver disease: what's in a name? |
| Q33433774 | Thrombopoietic cytokines in patients with hepatitis C virus-associated immune thrombocytopenia. |
| Q47764283 | Thrombotic thrombocytopenic purpura related to ADAMTS13 deficiency, and successful treatment in a chimpanzee (Pan troglodytes verus). |
| Q46811579 | Use of romiplostim allows for hepatitis C therapy in a HIV/HCV coinfected patient |
Search more.